ATE355834T1 - Verwendung von 4-oxo-butansäure derivaten zur behandlung der entzündung - Google Patents
Verwendung von 4-oxo-butansäure derivaten zur behandlung der entzündungInfo
- Publication number
- ATE355834T1 ATE355834T1 AT02779532T AT02779532T ATE355834T1 AT E355834 T1 ATE355834 T1 AT E355834T1 AT 02779532 T AT02779532 T AT 02779532T AT 02779532 T AT02779532 T AT 02779532T AT E355834 T1 ATE355834 T1 AT E355834T1
- Authority
- AT
- Austria
- Prior art keywords
- oxo
- acid derivatives
- treat inflammation
- butanic acid
- butanic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0115601A FR2832925B1 (fr) | 2001-12-03 | 2001-12-03 | Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE355834T1 true ATE355834T1 (de) | 2007-03-15 |
Family
ID=8870049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02779532T ATE355834T1 (de) | 2001-12-03 | 2002-11-06 | Verwendung von 4-oxo-butansäure derivaten zur behandlung der entzündung |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7897644B2 (de) |
| EP (1) | EP1450780B1 (de) |
| JP (1) | JP2005511654A (de) |
| KR (1) | KR20050043728A (de) |
| CN (1) | CN1599604A (de) |
| AT (1) | ATE355834T1 (de) |
| AU (1) | AU2002342883B2 (de) |
| BR (1) | BR0214644A (de) |
| CA (1) | CA2468910C (de) |
| DE (1) | DE60218726T2 (de) |
| ES (1) | ES2280589T3 (de) |
| FR (1) | FR2832925B1 (de) |
| HU (1) | HUP0402242A3 (de) |
| MX (1) | MXPA04005265A (de) |
| PL (1) | PL369845A1 (de) |
| RU (1) | RU2004120557A (de) |
| TW (1) | TW200300670A (de) |
| WO (1) | WO2003047561A1 (de) |
| ZA (1) | ZA200405246B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2368692T3 (es) | 2007-12-03 | 2011-11-21 | Merck Patent Gmbh | Utilización de derivados del ácido 4-oxobutanoico en el tratamiento de patologías asociadas con trastornos inmunológicos. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3784701A (en) * | 1970-09-21 | 1974-01-08 | American Cyanamid Co | Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain |
| JPS59144717A (ja) * | 1983-02-07 | 1984-08-18 | Microbial Chem Res Found | 鎮痛剤 |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| GB9522615D0 (en) * | 1995-11-03 | 1996-01-03 | Pharmacia Spa | 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| CO5011113A1 (es) * | 1996-05-15 | 2001-02-28 | Bayer Corp | Derivados de acido 3-arilbutirico sustituido como inhibidores de la metaloproteasa de matriz y composiciones farmaceuticas que los contienen |
| FR2752422B1 (fr) * | 1996-08-16 | 1998-11-06 | Lipha | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
| FR2777566B1 (fr) | 1998-04-15 | 2003-02-21 | Synthelabo | Derives d'azacycloalcanes, leur preparation et leur application en therapeutique |
| US6060250A (en) * | 1998-06-30 | 2000-05-09 | Incyte Pharmaceuticals, Inc. | Human transferases |
| AU4229499A (en) * | 1998-07-30 | 2000-02-21 | Warner-Lambert Company | Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases |
| FR2793411B1 (fr) * | 1999-05-11 | 2001-06-29 | Synthelabo | Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation |
| EP1295609A4 (de) * | 2000-02-24 | 2004-11-03 | Takeda Chemical Industries Ltd | Medikamente mit gemischten aktiven stoffen |
-
2001
- 2001-12-03 FR FR0115601A patent/FR2832925B1/fr not_active Expired - Fee Related
-
2002
- 2002-11-06 US US10/497,491 patent/US7897644B2/en not_active Expired - Fee Related
- 2002-11-06 PL PL02369845A patent/PL369845A1/xx unknown
- 2002-11-06 KR KR1020047006346A patent/KR20050043728A/ko not_active Application Discontinuation
- 2002-11-06 MX MXPA04005265A patent/MXPA04005265A/es unknown
- 2002-11-06 WO PCT/EP2002/012357 patent/WO2003047561A1/en active IP Right Grant
- 2002-11-06 CN CNA028241045A patent/CN1599604A/zh active Pending
- 2002-11-06 EP EP02779532A patent/EP1450780B1/de not_active Expired - Lifetime
- 2002-11-06 ES ES02779532T patent/ES2280589T3/es not_active Expired - Lifetime
- 2002-11-06 AT AT02779532T patent/ATE355834T1/de not_active IP Right Cessation
- 2002-11-06 BR BR0214644-4A patent/BR0214644A/pt not_active IP Right Cessation
- 2002-11-06 HU HU0402242A patent/HUP0402242A3/hu unknown
- 2002-11-06 JP JP2003548817A patent/JP2005511654A/ja not_active Ceased
- 2002-11-06 AU AU2002342883A patent/AU2002342883B2/en not_active Ceased
- 2002-11-06 CA CA2468910A patent/CA2468910C/en not_active Expired - Fee Related
- 2002-11-06 DE DE60218726T patent/DE60218726T2/de not_active Expired - Lifetime
- 2002-11-06 RU RU2004120557/15A patent/RU2004120557A/ru not_active Application Discontinuation
- 2002-11-29 TW TW091134839A patent/TW200300670A/zh unknown
-
2004
- 2004-07-01 ZA ZA200405246A patent/ZA200405246B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200300670A (en) | 2003-06-16 |
| FR2832925A1 (fr) | 2003-06-06 |
| EP1450780A1 (de) | 2004-09-01 |
| HUP0402242A3 (en) | 2006-01-30 |
| EP1450780B1 (de) | 2007-03-07 |
| DE60218726D1 (de) | 2007-04-19 |
| AU2002342883B2 (en) | 2007-11-29 |
| FR2832925B1 (fr) | 2006-07-14 |
| ZA200405246B (en) | 2005-06-24 |
| AU2002342883A1 (en) | 2003-06-17 |
| KR20050043728A (ko) | 2005-05-11 |
| US20050014768A1 (en) | 2005-01-20 |
| MXPA04005265A (es) | 2004-10-11 |
| JP2005511654A (ja) | 2005-04-28 |
| PL369845A1 (en) | 2005-05-02 |
| CA2468910C (en) | 2012-01-03 |
| US7897644B2 (en) | 2011-03-01 |
| WO2003047561A1 (en) | 2003-06-12 |
| HUP0402242A2 (hu) | 2005-02-28 |
| CN1599604A (zh) | 2005-03-23 |
| CA2468910A1 (en) | 2003-06-12 |
| BR0214644A (pt) | 2004-11-03 |
| DE60218726T2 (de) | 2007-11-15 |
| ES2280589T3 (es) | 2007-09-16 |
| RU2004120557A (ru) | 2005-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE411280T1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
| EA200870127A1 (ru) | Полициклические производные аминокислот и способы их применения | |
| ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| ES2171723T3 (es) | 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2. | |
| ATE326466T1 (de) | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion | |
| ATE461697T1 (de) | Phospholipidderivate von valproinsäure und ihre kombinationen | |
| DE60140871D1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| DE60233433D1 (de) | PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN | |
| ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
| ATE415965T1 (de) | Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung | |
| ES2147973T3 (es) | Estirenos alquilatados como profarmacos de inhibidores de cox-2. | |
| ES2182035T3 (es) | Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa. | |
| ATE267816T1 (de) | Tan-1057 derivate | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| EE9800230A (et) | Difenüülstilbeenid kui COX-2 inhibiitorite eelravimid | |
| ATE361071T1 (de) | Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie | |
| DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| ATE315387T1 (de) | Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |